AI Article Synopsis

  • - Lipodystrophy is a condition where there is a significant loss of fat tissue, either completely or partially.
  • - The causes of lipoatrophy can be congenital, acquired due to trauma or medical treatment, or even unknown, with rare instances linked to vaccinations.
  • - This report details a unique case of lipodystrophy occurring in a 55-year-old woman after receiving the COVID-19 Sinopharm vaccine.

Article Abstract

Lipodystrophy is a medical condition characterized by complete or partial loss of adipose tissue. The etiology of lipoatrophy can be congenital or acquired, including traumatic, iatrogenic, or idiopathic. Rarely, vaccination can cause lipodystrophy. Here, we report the first case of lipodystrophy associated with the COVID-19 Sinopharm vaccine in a 55-year-old woman.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11292498PMC
http://dx.doi.org/10.1016/j.jvacx.2024.100513DOI Listing

Publication Analysis

Top Keywords

lipodystrophy
4
lipodystrophy covid-19
4
covid-19 vaccination
4
vaccination case
4
case report
4
report lipodystrophy
4
lipodystrophy medical
4
medical condition
4
condition characterized
4
characterized complete
4

Similar Publications

Background: Medications targeting the leptin and Apolipoprotein CIII (APOC3) pathways are currently under development for the treatment of hypertriglyceridaemia. Given that both pathways are implicated in triglyceride regulation, it is unknown whether they function independently or interact under physiological conditions and under acute or long-term energy deficiency.

Methods: APOC3 levels and their association with circulating lipids and lipoproteins were evaluated in the context of two randomised controlled studies.

View Article and Find Full Text PDF

Background: Lipodystrophy encompasses a group of rare disorders associated with severe metabolic disease. These disorders are defined by abnormal fat distribution, with near-total (generalized lipodystrophy, GL) or partial (partial lipodystrophy, PL; i.e.

View Article and Find Full Text PDF

Berardinelli-Seip congenital lipodystrophy (BSCL), also known as congenital generalized lipodystrophy (CGL), is an exceptionally rare autosomal recessive disorder marked by a significant deficiency of adipose tissue throughout the body. This lack of adipose tissue, normally found beneath the skin and between internal organs, leads to impaired adipocyte formation and fat storage, causing lipids to accumulate in atypical tissues such as muscles and the liver. The extent of adipose tissue loss directly influences the severity of symptoms, which can include a muscular appearance, increased appetite, bone cysts, marrow fat depletion, acromegalic features, severe insulin resistance, skeletal muscle hypertrophy, hypertrophic cardiomyopathy, hepatic steatosis, hepatomegaly, cirrhosis, and intellectual disability.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!